ロード中...
Discussion of Trial Designs for Biomarker Identification and Validation Through the Use of Case Studies
With the launch of the National Cancer Institute’s Precision Medicine Initiative in 2015, there has been a shift to trial designs that tailor health care solutions to individual patients by using a screening platform and by moving away from the one-trial/one-biomarker-at-a-time approach. To make pre...
保存先:
| 出版年: | JCO Precis Oncol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Clinical Oncology
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7079723/ https://ncbi.nlm.nih.gov/pubmed/32190807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.19.00051 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|